Background Postoperative microbial keratitis (MK) can cause graft failure and vision loss following keratoplasty for corneal ...

New program unveiled: Lineage introduced COR1, a wholly owned corneal endothelial cell transplant initiative, leveraging its AlloSCOPE platform. Regulatory rethink: UK’s MHRA and US FDA are updating ...

We need to remember a few facts about this study. It was only for eyes with endothelial dysfunction causing corneal edema -- that is, not for keratoconus, stromal dystrophies, or corneal scars. The ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

ORLANDO -- Receiving corneal tissue from donors with and without diabetes didn't negatively affect patients who underwent Descemet membrane endothelial keratoplasty (DMEK), a form of partial corneal ...

Aurion Biotech, Inc. ("Aurion Biotech"), a commercial-stage regenerative cell therapy company dedicated to restoring vision and working toward a future where blindness is eliminated, today announced ...

Lineage Cell Therapeutics Inc (LCTX) showcases promising program developments and a robust cash position, despite facing operational challenges and increased net loss.

New Internally-Developed and Wholly-Owned Asset Benefits From Existing Ophthalmology and Manufacturing Expertise Fuchs Endothelial Corneal Dystrophy (FECD) Afflicts More Than 7.3% of the Population ...

Many eye banks won’t accept corneas from donors with diabetes, concerned they might be harder to prepare for transplant surgery or are more likely to fail. “We also found the severity of the donor’s ...

Researchers at Harvard Medical School have demonstrated the potent therapeutic effects of administration of the neuropeptide α-melanocyte–stimulating hormone (α-MSH) through melanocortin receptor ...